Choriogonadotropin alfa
Ovidrel, Ovitrelle (choriogonadotropin alfa) is a protein pharmaceutical. Choriogonadotropin alfa was first approved as Ovidrel on 2000-09-20. It is used to treat cryptorchidism, female infertility, and hypogonadism in the USA. It has been approved in Europe to treat anovulation, assisted reproductive techniques, and female infertility.
| Trade Name | Ovitrelle |
|---|---|
| Common Name | Choriogonadotropin alfa |
| Indication | anovulation, assisted reproductive techniques, cryptorchidism, female infertility, hypogonadism |
| Drug Class | Tricyclic compounds; atropine derivatives |
